Clinical characteristics and prognostic factors affecting survival after radical radiotherapy for early and late post-treatment metastatic nasopharyngeal carcinoma

por Jia, Guo-Dong, Sun, Xue-Song, Li, Xiao-Yun, Liu, Sai-Lan, Yang, Jin-Hao, Chen, Qiu-Yan, Yuan, Li, Mai, Hai-Qiang
Publicado 2023

Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy

por Yang, Jin-Hao, Sun, Xue-Song, Xiao, Bei-Bei, Liu, Li-Ting, Guo, Shan-Shan, Liang, Jia-Dong, Jia, Guo-Dong, Tang, Lin-Quan, Chen, Qiu-Yan, Mai, Hai-Qiang
Publicado 2021

Identifying optimal candidates for induction chemotherapy among stage II–IVa nasopharyngeal carcinoma based on pretreatment Epstein–Barr virus DNA and nodal maximal standard uptake...

por Xie, Hao‐Jun, Yu, Yi‐Fei, Sun, Xue‐Song, Jia, Guo‐Dong, Luo, Dong‐Hua, Sun, Rui, Liu, Li‐Ting, Guo, Shan‐Shan, Liu, Sai‐Lan, Chen, Qiu‐Yan, Tang, Lin‐Quan, Mai, Hai‐Qiang
Publicado 2020

Intensive Local Radiotherapy Is Associated With Better Local Control and Prolonged Survival in Bone-Metastatic Nasopharyngeal Carcinoma Patients

por Li, Xiao-Yun, Jia, Guo-Dong, Sun, Xue-Song, Guo, Shan-Shan, Liu, Li-Ting, Liu, Sai-Lan, Yan, Jin-Jie, Luo, Dong-Hua, Sun, Rui, Guo, Ling, Mo, Hao-Yuan, Tang, Lin-Quan, Chen, Qiu-Yan, Mai, Hai-Qiang
Publicado 2020

Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2...

por Yuan, Li, Jia, Guo-Dong, Lv, Xiao-Fei, Xie, Si-Yi, Guo, Shan-Shan, Lin, Da-Feng, Liu, Li-Ting, Luo, Dong-Hua, Li, Yi-Fu, Deng, Shen-Wen, Guo, Ling, Zeng, Mu-Sheng, Cai, Xiu-Yu, Liu, Sai-Lan, Sun, Xue-Song, Li, Xiao-Yun, Li, Su-Chen, Chen, Qiu-Yan, Tang, Lin-Quan, Mai, Hai-Qiang
Publicado 2023